U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 22-28, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 22-28, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

No Significant Event

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 01/24/2023
Location: Virtual
Subject: Food Integrity U.S. 2023 Online Summit; Speaker: Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, and other stakeholders

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 01/25/2023
Location: Virtual
Subject: Office of Global Policy and Strategy Newsletter Interview
FDA Participant/Group: KAREN RILEY;
Non FDA Participant/Group: Paul Huleatt (World Health Organization Member State Mechanism on Substandard and Falsified Medical Products);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/24/2023
Location: Virtual
Subject: Duke Clinical Research Institute Research Forum: Unlocking the Promise of Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare and academia stakeholders

Event Date: 01/25/2023
Location: Virtual
Subject: Precision Medicine World Conference 2023 - Gene and Cell Therapies Track; Panel Chair: From Bench to Bedside - Biomarkers, Natural History Studies, Animal Models
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare, academia, and research stakeholders

Event Date: 01/26/2023
Location: Virtual
Subject: Vaccines and Related Biological Products Advisory Committee; Welcome Address
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and public stakeholders

Event Date: 01/27/2023
Location: Washington, DC
Subject: Alliance for Aging Research and American Society of Consultant Pharmacists; Panelist: Our Best Shot: A Roundtable on Expanding Vaccine Access for Long-Term Care Residents
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare and public stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 01/24/2023
Location: Virtual
Subject: Listening Session: Presentation on the Evaluation of Action on Smoking and Health (ASH) Canada’s Tobacco Retailer Advanced Compliance (TRAC) Online Training Program
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from Action on Smoking and Health (ASH) Canada

Official Name: Tracey H. Forfa, J.D., Acting Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top